Geron lands potential $900M blood cancer drug deal with J&J
November 13, 2014 at 17:59 PM EST
Geron Corp. will hand over its experimental blood cancer drug imetelstat to Johnson & Johnson's Janssen Biotech Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.